مستشفى Ruber Internacional
مستشفى Ruber Internacional
إسبانيا, مدريد
Roberto Martínez Álvarez
42سنة خبره ١٦ سنة
العيادة معتمدة من قبل :
| تركيا | إسبانيا | ألمانيا | |
| علاج الخلايا الجذعية لمرض الزهايمر | من $15,000 | من $20,000 | من $30,000 |
مخترع مكرم حاصل على 62 براءة اختراع دولية – الدكتور بلوم رائد في تقنيات إعادة التأهيل الجديدة في معهد الأبحاث الخاص به لإعادة التأهيل السريري.
أكثر من 180 منشوراً و230 مشاركة متحدثة – الدكتور مارتينيز ألفاريز هو جراح أعصاب مشهور متخصص في جراحة الأعصاب الوظيفية في مستشفى روبر الدولي.
تتمتع الدكتورة آنا بوجول بـ 36 عاماً من الخبرة في مجال طب الأعصاب، وتتخصص في مرض الزهايمر في مركز تكنون الطبي (Centro Médico Teknon).
رئيس وحدة العلوم العصبية المتقدمة في كيرونسالود – يركز الدكتور توريس على الرعاية التي تتمحور حول المريض للاضطرابات التنكسية العصبية مثل مرض الزهايمر.
No medication currently exists to fully cure Alzheimers disease in Spain. However, Spanish clinics employ newly authorized disease-modifying therapies like Lecanemab and Donanemab. These drugs target amyloid plaques to slow cognitive decline by 27% to 35% in early-stage patients.
Bookimed Expert Insight: Spain is a global leader in neuro-research, ranking third in our network for complex neurology requests. Clinics like Quironsalud Madrid may offer eligible international patients access to clinical trials for free. This provides a unique route to experimental treatments not yet available for general purchase in other regions.
Patient Consensus: Patients emphasize that while no cure exists, securing a private MRI and specialist consultation quickly is vital. They often prefer the Mediterranean lifestyle and diet in Spain as practical supports to clinical symptom management.
Lecanemab is accessible in Spain through clinical trials and compassionate use programs. The Spanish Agency for Medicines and Health Products (AEMPS) is currently evaluating public funding. Treatment targets early-stage patients with limited ApoE4 gene copies. Administration requires specialized JCI-accredited centers for MRI monitoring.
Bookimed Expert Insight: Spanish healthcare centers like Quironsalud Madrid focus heavily on clinical trials for neurodegenerative disorders. Patients can often access therapies like Lecanemab for free by participating in these studies. This is a vital alternative while national reimbursement remains under public evaluation.
Patient Consensus: Patients note it's important to have APOE4 testing and MRI results ready before seeking private treatment. Families often find that private access in Barcelona or Madrid is currently the only non-trial option available.
Stem cell therapy for Alzheimer's disease in Spain is exclusively available through authorized clinical trials and rigorous research programs. While hematopoietic and orthopedic applications are standard, neurological uses remain experimental. Facilities like Quironsalud Madrid participate in specific research trials for neurodegenerative disorders under strict regulatory oversight.
Bookimed Expert Insight: Spain's high global rank for medical requests reflects its strict adherence to European standards. Data shows clinics like Quironsalud Madrid and HM Madrid prioritize large-scale clinical trials over commercial experimental packages. Patients should look for centers with over 20,000 annual operations as they typically possess the infrastructure for advanced research protocols.
Patient Consensus: Patients note it is vital to verify trials via official databases like clinicaltrials.gov to avoid unproven clinics. Many emphasize that legal therapies for cognitive conditions are not yet available as standard private treatments.
Madrid and Barcelona are the primary hubs for clinical Alzheimer's care in Spain. Madrid offers extensive research clinical trials at centers like Quironsalud Madrid. Barcelona provides advanced diagnostics at JCI-accredited facilities. Regions like Costa del Sol and Costa Blanca are preferred for long-term residential support.
Bookimed Expert Insight: Madrid stands out for high-volume care with Hospital Ruber Internacional treating 25,000 patients annually. While smaller centers like Dr. Blum’s Biomechanics Center in Marbella serve only 120 patients yearly. This suggests patients prioritize Madrid for diagnostic speed and Marbella for intimate, long-term rehabilitation.
Patient Consensus: Patients value the milder southern climate but warn that specialized diagnostics often require travel to Madrid. Families note it is critical to confirm electronic access to imaging results before finishing treatment.
Spains National Health System (SNS) provides free diagnosis, neurologist referrals, and imaging for residents. Patients typically pay only 10% for approved medications like cholinesterase inhibitors. While medical care is fully covered, social support services often require means-tested copayments and feature long waiting lists.
Bookimed Expert Insight: Spain ranks third globally in our data for neurological care requests. High-volume centers like HM Hospitales manage over 2 million outpatients annually. This scale allows clinics to participate in major clinical trials for neurodegenerative disorders. Patients seeking the latest therapies often choose these high-volume research hubs over smaller regional centers.
Patient Consensus: Patients value the free diagnostics but often transition to private specialists for faster access to cognitive therapy. Many note that while basic medications are covered, families should budget for private non-drug rehabilitation to avoid public waiting lists.
Spain provides extensive support for Alzheimer's families through state subsidies, specialized NGOs, and accredited medical research centers. Caregivers can access monthly allowances between €180 and €455, while specific foundations offer respite care, training, and bilingual assistance for international families managing cognitive decline.
Bookimed Expert Insight: While public aid covers basic needs, families often choose private networks like Quironsalud for specialized diagnostics. Quironsalud Madrid is a research hub for Alzheimer's and Parkinson's, potentially offering patients access to experimental protocols not available in primary care settings. This makes Madrid a strategic center for families seeking both state-level support and advanced medical intervention.
Patient Consensus: Patients note it is important to contact local town halls for home help services, which typically provide ten hours of weekly assistance. International families highlight the value of organizations like Age in Spain for navigating residency-linked benefits in English.